Document is current
Any future updates will be listed below
-
Authors
Brink, Kathryn R. https://orcid.org/0000-0002-5155-9336
Hunt, Maxwell G. https://orcid.org/0000-0002-8842-0776
Mu, Andrew M. https://orcid.org/0000-0003-3812-2719
Groszman, Ken https://orcid.org/0000-0003-4763-5372
Hoang, Ky V. https://orcid.org/0000-0001-9104-8584
Lorch, Kevin P. https://orcid.org/0000-0002-2274-257X
Pogostin, Brett H. https://orcid.org/0000-0002-1462-4442
Gunn, John S. https://orcid.org/0000-0003-2848-8346
Tabor, Jeffrey J. https://orcid.org/0000-0001-7316-0361
-
Funding
Funding for this research was provided by:
Rice University
National Science Foundation (1553317)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI155586-01A1)
Welch Foundation (C-1856)
- License Information
-
More Information
Article History
Received: 17 May 2021
Accepted: 10 October 2022
First Online: 8 December 2022
Competing interests
: Rice University has filed a patent application including the use of PhoPQ for host peptide biosensing. J.J.T. is a founder of Pana Bio, a company that aims to commercialize diagnostic and therapeutic bacteria. The remaining authors declare no competing interests.
